Tratamiento quirúrgico de la carcinomatosis de origen colorrectal

Cirugia Espanola

Volumn 75, Issue 3, 2004, Pages 156-

  Gómez Portilla, Alberto ^a  

^a Policlínica San José   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748315974     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(04)78948-4     Document Type: Letter

References (9)

1. Ortiz-Hurtado H. Tratamiento quirúrgico y resultados del cáncer de colon. Cir Esp. 2003;73:1-73.
2. Guillem JG, Sigurdson ER. Colorectal Cancer. Surg Clin N Am 2002;82:891-1114.
3. Pestieau SR, Sugarbaker PH. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis Colon Rectum 2000;43:1341-8.
4. Schneebaum S, Arnold MW, Staubus A, et al. Intraperitoneal hyperthermic perfusion with mitomycin-C for colorectal cancer with peritoneal metastases. Ann Surg Oncol 1996;3:44-50.
5. Loggie BW, Fleming RA, McWuellen RP, et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surgeon 2000;66:561-8.
6. Cavaliere F, Perri P, Di Filippo F, et al. Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol 2000;74:41-4.
7. Witkamp AJ, De Bree E, Van Goethem AR, et al. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 2001;27:365-74.
8. Elias D, Dubé P, Blot F, et al. Peritoneal carcinomatosis treatment with curative intent: the Institut Gustave-Roussy experience. Eur J Surg Onc 1977;23:317-21.
9. Shen P, Levine EA, Hall J, Case D, Russell G, Fleming R, et al. Factors predicting survival after intraperitoneal hyperthemic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003;138:26-33.